Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Dec 6 2019

Full Issue

Veritas Suspends Operations In Another Sign Of Gene-Testing Companies Losing Footing In Consumer Market

Giants like 23andMe continue to dominate, but smaller firms like Veritas have had to pare back expectations. Veritas was known as one of the few companies providing whole-genome sequencing.

Stat: Veritas Genetics Suspends Its U.S. Operations 

Veritas Genetics, the Boston-based personal genome testing company co-founded by noted Harvard Medical School professor George Church, suspended its operations in the United States, according to a statement the company posted Thursday on Twitter. The company experienced “an unexpected adverse financing situation,” according to the posted statement. “We are currently assessing all paths forward, including strategic options.” (Sheridan, 12/5)

CNBC: Veritas Genetics To Cease US Operations, Talks With Buyers

The company also laid off the bulk of its employees based in the U.S., about 50 people, earlier this week, according to a source familiar with the company. The source asked not to be named because they were not authorized to speak for Veritas Genetics. “I can clarify this temporarily affects U.S. operations only,” a spokesperson for the company said. “All of the customers outside of the U.S. will continue to be served by Veritas Europe and Latin America.” (Farr, 12/5)

In other health industry news —

Stat: Gates Foundation CEO Susan Desmond-Hellmann To Step Down

Sue Desmond-Hellmannn is stepping down as CEO of the Bill and Melinda Gates Foundation, the world’s largest funder of biomedical research. In a statement, she cited health and family reasons for the move. Desmond-Hellmann will be replaced by Mark Suzman, the foundation’s president of global policy and advocacy and chief strategy officer, on Feb. 1. (Branswell, 12/5)

Modern Healthcare: Primary-Care Provider ChenMed To Enter Five New Markets

Miami-based primary care provider ChenMed plans to expand into the Cleveland market, as well as into Cincinnati, Memphis, Orlando and St. Louis, while growing within its current 14 markets. ChenMed announced Tuesday, Dec. 3, that it plans to establish multiple Dedicated Senior Medical Centers in each of the five new cities, opening a total of 20 new medical practices in the next year. It aims to transform primary care for tens of thousands of presently underserved seniors, according to a news release. (Coutré, 12/5)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
  • Thursday, May 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF